We are live on ! Find out more
HAE icon

Haemonetics

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 328324 (-4)

6.15% less ownership

Funds ownership: 108.62%102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M
Name Holding Trade Value Shares
Change
Change in
Stake
HSA
176
Hussman Strategic Advisors
Maryland
$592K +$684K +10,500 New
Thrivent Financial for Lutherans
177
Thrivent Financial for Lutherans
Minnesota
$590K -$4.62K -71 -0.7%
PA
178
Pinnacle Associates
New York
$589K +$681K +10,456 New
NMIMC
179
Northwestern Mutual Investment Management Company
Wisconsin
$587K -$4.1K -63 -0.6%
NMERB
180
New Mexico Educational Retirement Board
New Mexico
$581K
Carson Wealth (CWM LLC)
181
Carson Wealth (CWM LLC)
Nebraska
$575K -$164K -2,523 -20%
Millennium Management
182
Millennium Management
New York
$551K -$2.93M -45,037 -82%
OPERF
183
Oregon Public Employees Retirement Fund
Oregon
$535K +$6.51K +100 +1%
II
184
Inspire Investing
Idaho
$513K +$213K +3,272 +56%
Stifel Financial
185
Stifel Financial
Missouri
$508K +$134K +2,057 +30%
FGP
186
Freestone Grove Partners
California
$506K +$584K +8,972 New
ProShare Advisors
187
ProShare Advisors
Maryland
$489K -$131K -2,015 -19%
Bank of Montreal
188
Bank of Montreal
Ontario, Canada
$486K +$296K +4,540 +111%
SCP
189
Sivia Capital Partners
California
$473K +$164K +2,524 +43%
VI
190
Vestcor Inc
New Brunswick, Canada
$468K +$294K +4,516 +120%
WG
191
Winton Group
United Kingdom
$434K +$501K +7,700 New
AC
192
Allstate Corporation
Illinois
$432K +$499K +7,661 New
SOADOR
193
State of Alaska Department of Revenue
Alaska
$431K
Pictet Asset Management
194
Pictet Asset Management
Switzerland
$418K +$39.7K +610 +9%
JPLA
195
Joseph P. Lucia & Associates
New York
$381K -$88.1K -1,352 -17%
X
196
Xponance
Pennsylvania
$377K +$58.2K +893 +15%
CRC
197
Curi RMB Capital
Illinois
$370K -$23.8K -366 -5%
Blackstone Inc
198
Blackstone Inc
New York
$361K +$417K +6,400 New
DFCM
199
Dark Forest Capital Management
Puerto Rico
$347K -$592K -9,085 -60%
MAM
200
Martingale Asset Management
Massachusetts
$333K +$384K +5,901 New

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.